Lek Marks Birthday with New Biopharmaceutical Centre
Mengeš, 28 September - Pharma company Lek, operating as part of Sandoz, the generic arm of Swiss pharmaceutical giant Novartis, has marked its 60th anniversary with a major investment as it began building a 2,800 sq. metre biopharmaceutical development centre just outside Ljubljana.
The rest of this news item is available to subscribers.
The news item consists of 539 characters (without spaces) or 106 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.